CHF417.00
0.60%
SIX Swiss Exchange, Jun 10, 10:46 am CET
ISIN
CH0019396990
Symbol
YPSN
Sector

Ypsomed Target price 2025 - Analyst rating & recommendation

Ypsomed Classifications & Recommendation:

Buy
75%
Hold
25%

Ypsomed Price Target

Target Price CHF429.29
Price CHF414.50
Potential
Number of Estimates 8
8 Analysts have issued a price target Ypsomed 2026 . The average Ypsomed target price is CHF429.29. This is higher than the current stock price. The highest price target is
CHF495.00 19.42%
register free of charge
, the lowest is
CHF330.32 20.31%
register free of charge
.
A rating was issued by 8 analysts: 6 Analysts recommend Ypsomed to buy, 2 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Ypsomed stock has an average upside potential 2026 of . Most analysts recommend the Ypsomed stock at Purchase.

Sales and Margin forecast 2026, 2027 & 2028

Create a premium account to unlock analyst estimates. Learn more

Mar '25 2026
Estimates
Revenue Million CHF 748.87 753.57
36.54% 0.63%
EBITDA Margin 25.74% 43.24%
12.34% 67.96%
Net Margin 11.68% 31.63%
18.23% 170.71%

5 Analysts have issued a sales forecast Ypsomed 2026 . The average Ypsomed sales estimate is

CHF754m
Unlock
. This is
0.63% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
CHF797m 6.43%
Unlock
, the lowest is
CHF726m 3.01%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2025 CHF749m 36.54%
2026
CHF754m 0.63%
Unlock
2027
CHF788m 4.63%
Unlock
2028
CHF919m 16.60%
Unlock

5 Analysts have issued an Ypsomed EBITDA forecast 2026. The average Ypsomed EBITDA estimate is

CHF326m
Unlock
. This is
69.01% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
CHF389m 101.88%
Unlock
, the lowest is
CHF279m 44.96%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2025 CHF193m 19.69%
2026
CHF326m 69.01%
Unlock
2027
CHF345m 5.78%
Unlock
2028
CHF395m 14.48%
Unlock

EBITDA Margin

2025 25.74% 12.34%
2026
43.24% 67.96%
Unlock
2027
43.71% 1.09%
Unlock
2028
42.92% 1.81%
Unlock

4 Ypsomed Analysts have issued a net profit forecast 2026. The average Ypsomed net profit estimate is

CHF238m
Unlock
. This is
172.38% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
CHF431m 392.65%
Unlock
, the lowest is
CHF163m 86.18%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 CHF87.5m 11.65%
2026
CHF238m 172.38%
Unlock
2027
CHF219m 7.93%
Unlock
2028
CHF249m 13.34%
Unlock

Net Margin

2025 11.68% 18.23%
2026
31.63% 170.71%
Unlock
2027
27.83% 12.01%
Unlock
2028
27.05% 2.80%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 & 2028

Create a premium account to unlock analyst estimates. Learn more

Mar '25 2026
Estimates
Earnings Per Share CHF 6.41 17.46
11.67% 172.39%
P/E 23.74
EV/Sales 7.94

4 Analysts have issued a Ypsomed forecast for earnings per share. The average Ypsomed EPS is

CHF17.46
Unlock
. This is
172.39% higher
Unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
CHF31.58 392.67%
Unlock
, the lowest is
CHF11.93 86.12%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 CHF6.41 11.67%
2026
CHF17.46 172.39%
Unlock
2027
CHF16.08 7.90%
Unlock
2028
CHF18.22 13.31%
Unlock

P/E ratio

Current 64.66 5.91%
2026
23.74 63.29%
Unlock
2027
25.79 8.64%
Unlock
2028
22.75 11.79%
Unlock

Based on analysts' sales estimates for 2026, the Ypsomed stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 7.99 21.28%
2026
7.94 0.66%
Unlock
2027
7.59 4.43%
Unlock
2028
6.51 14.24%
Unlock

P/S ratio

Current 7.55 23.15%
2026
7.50 0.62%
Unlock
2027
7.17 4.43%
Unlock
2028
6.15 14.24%
Unlock

Current Ypsomed Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
RESEARCH PARTNERS AG
Locked
Locked
Locked Dec 22 2024
BNP PARIBAS EXANE
Locked
Locked
Locked Nov 24 2024
ODDO BHF
Locked
Locked
Locked Nov 12 2024
Analyst Rating Date
Locked
RESEARCH PARTNERS AG:
Locked
Locked
Dec 22 2024
Locked
BNP PARIBAS EXANE:
Locked
Locked
Nov 24 2024
Locked
ODDO BHF:
Locked
Locked
Nov 12 2024

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today